These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6682249)

  • 1. Iliopelvic lymphoscintigraphy.
    Kaplan WD
    Semin Nucl Med; 1983 Jan; 13(1):42-53. PubMed ID: 6682249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented iliopelvic lymphoscintigraphy: application in the management of genitourinary malignancy.
    Ege GN
    J Urol; 1982 Feb; 127(2):265-9. PubMed ID: 7062381
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of lymphoscintigraphy in urological disease].
    Sato T; Hiraiwa S; Yamada Y; Muramatsu T; Nishikawa E; Fukatsu H; Segawa A
    Hinyokika Kiyo; 1984 Nov; 30(11):1589-98. PubMed ID: 6528842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of lymphoscintigraphy, lymphangiography and computer tomography scanning in the preoperative assessment of lymph nodes involved by pelvic malignant conditions.
    Feigen M; Crocker EF; Read J; Crandon AJ
    Surg Gynecol Obstet; 1987 Aug; 165(2):107-10. PubMed ID: 3603339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct comparison between subcutaneous and intralymphatic injections for lymphoscintigraphy.
    Gibson CJ; Vijayasimhulu GT; Diffey BL
    Clin Radiol; 1984 Jan; 35(1):81-3. PubMed ID: 6690187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of lymphoscintigraphy in oncologic practice: principles and differences vis-a-vis other imaging modalities.
    Croll MN; Brady LW; Dadparvar S
    Semin Nucl Med; 1983 Jan; 13(1):4-8. PubMed ID: 6682248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of lymphoscintigraphy by rectal submucosal injection of radioactive colloid].
    Hong SS; Tokumoto Y; Kawai T; Takahashi T; Takahashi S; Nomura E; Yamada Y; Yabe H; Umegaki Y
    Radioisotopes; 1983 Nov; 32(11):546-50. PubMed ID: 6675058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.
    Wanebo HJ; Harpole D; Teates CD
    Cancer; 1985 Mar; 55(6):1403-13. PubMed ID: 3971311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of lymph node invasion in prostatic carcinoma with iliopelvic lymphoscintigraphy.
    Horenblas S; Nuyten MJ; Hoefnagel CA; Moonen LM; Delemarre JF
    Br J Urol; 1992 Feb; 69(2):180-2. PubMed ID: 1537030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoscintigraphy for interpretation of changes of cervical lymph node function in patients with oral malignant tumors: comparison of Tc-99m-Re and Tc-99m-HSA-D.
    Sato T; Yamaguchi K; Morita Y; Noikura T; Sugihara K; Matsune S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):525-37. PubMed ID: 11027392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful internal mammary visualization with periareolar injections of Tc-99m antimony sulfur colloid in sentinel node breast lymphoscintigraphy.
    Ting AC; Cumarasingam B; Szeto ER
    Clin Nucl Med; 2006 Oct; 31(10):593-7. PubMed ID: 16985361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m antimony sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection.
    Zuckier LS; Finkelstein M; Kreutzer ER; Stone PL; Freed SZ; Bard RH; Blaufox MD; Freeman LM
    Nucl Med Commun; 1990 Sep; 11(9):589-96. PubMed ID: 2234694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iliopelvic radionuclide lymphoscintigraphy in patients with testicular cancer.
    Kaplan WD; Garnick MB; Richie JP
    Radiology; 1983 Apr; 147(1):231-5. PubMed ID: 6828735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lymphoscintigraphy in malignant melanoma.
    Bennett LR; Lago G
    Semin Nucl Med; 1983 Jan; 13(1):61-9. PubMed ID: 6836319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
    McLean RG; Ege GN
    J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy.
    O'Brien CJ; Uren RF; Thompson JF; Howman-Giles RB; Petersen-Schaefer K; Shaw HM; Quinn MJ; McCarthy WH
    Am J Surg; 1995 Nov; 170(5):461-6. PubMed ID: 7485733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmaceuticals in sentinel lymph-node detection - an overview.
    Wilhelm AJ; Mijnhout GS; Franssen EJ
    Eur J Nucl Med; 1999 Apr; 26(4 Suppl):S36-42. PubMed ID: 10199931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphy in patients with malignant melanoma: a quantitative and qualitative evaluation of its usefulness.
    Bergqvist L; Strand SE; Hafström L; Jönsson PE
    Eur J Nucl Med; 1984; 9(3):129-35. PubMed ID: 6714247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node detection and definition may depend on the imaging agent and timing.
    Boxen I; McCready D; Ballinger JR
    Clin Nucl Med; 1999 Jun; 24(6):390-4. PubMed ID: 10361932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High colloidal uptake in axillary nodes with metastatic disease.
    Peyton JW; Crosbie J; Bell TK; Roy AD; Odling-Smee W
    Br J Surg; 1981 Jul; 68(7):507-9. PubMed ID: 7248724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.